Leflunomide
Rank #463 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$16.0M
Total Cost
205,765
Total Claims
$16.0M
Total Cost
3,273
Prescribers
$78
Cost per Claim
55,870
Beneficiaries
416,378
30-Day Fills
$4,875
Avg Cost/Provider
63
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$16.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $16.0M total
Top Prescribers of Leflunomide
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mansoor Ahmed | Rheumatology | Richmond, KY | 921 | $87K |
| 2 | Steven Cohen | Rheumatology | Tyler, TX | 1,150 | $83K |
| 3 | Noemi Varela-Rosario | Internal Medicine | Aguada, PR | 1,223 | $69K |
| 4 | William Rusche | Rheumatology | Bloomington, IN | 393 | $55K |
| 5 | Isam Diab | Rheumatology | Middleburg Hts, OH | 474 | $50K |
| 6 | Sheila Albuquerque | Rheumatology | Houston, TX | 174 | $44K |
| 7 | Lucia Hardi | Rheumatology | Lexington, KY | 313 | $44K |
| 8 | Thomas Conley | Rheumatology | Franklin, MA | 389 | $42K |
| 9 | Vinay Reddy | Rheumatology | Merrillville, IN | 292 | $41K |
| 10 | Maria Jones | Nurse Practitioner | Miamisburg, OH | 375 | $39K |
| 11 | Laura Howe | Rheumatology | Greeley, CO | 500 | $38K |
| 12 | Abdelnaser Elkhalili | Rheumatology | Webster, TX | 416 | $38K |
| 13 | Justina Tseng | Rheumatology | San Diego, CA | 292 | $37K |
| 14 | Daniel Jackson | Rheumatology | Akron, OH | 216 | $37K |
| 15 | Jorge Mundo | Rheumatology | Humacao, PR | 452 | $37K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
| 463 | Leflunomide (Leflunomide) | $16.0M | 205,765 |
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
| 465 | Digoxin (Digoxin) | $15.9M | 548,410 |
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology